Aruna Kamineni, PhD, MPH
“I'm working on reducing cancer through better screening. I collaborate with researchers nationwide on studies that will make screening more effective, patient-friendly, and personalized.”
Aruna Kamineni, PhD, MPH
Assistant Investigator, Kaiser Permanente Washington Health Research Institute
Aruna.S.Kamineni@kp.org
206-287-2922
Biography
Aruna Kamineni, PhD, MPH, came to Kaiser Permanente Washington Health Research Institute in 2009 with a wealth of experience in chronic disease epidemiology. Dr. Kamineni has expertise in using case-control methods to evaluate screening efficacy, and her research focuses on addressing evidence gaps for clinical guidelines, particularly for cervical and colorectal cancer prevention. A substantial portion of her work has focused on developing infrastructure and methods for research using electronic clinical and administrative health care data.
Since 2011, Dr. Kamineni has participated in the National Cancer Institute’s Population-based Research to Optimize the Screening Process (PROSPR) consortium to evaluate and improve cancer screening in U.S. community settings. As a principal investigator for multisite cervical and colorectal cancer PROSPR Research Centers, Dr. Kamineni is leading and collaborating on work to determine how to optimally use screening tests and consider how to tailor screening for population subgroups.
Dr. Kamineni’s research goals include studying the impact of human papillomavirus (HPV) DNA testing and HPV vaccination on cervical cancer and screening programs. Multidisciplinary collaboration is a valued and important driver of Dr. Kamineni’s research and she embraces a team science approach to optimizing cancer prevention.
Research interests and experience
-
Cancer
Cervical cancer; colorectal cancer; screening; disparities
-
Methods
Electronic clinical and administrative data infrastructure development for research; case-control studies; team science
-
Preventive Medicine
-
Women's Health
-
Cardiovascular Health
-
Chronic Illness Management
Recent publications
Alimena S, Lykken JM, Tiro JA, Chubak J, Kamineni A, Haas JS, Werner C, Kobrin SC, Feldman S Timing of Colposcopy and Risk of Cervical Cancer 2023 Nov;142(5):1125-1134. doi: 10.1097/AOG.0000000000005313. Epub 2023-08-22. PubMed
Dalmat RR, Ziebell RA, Kamineni A, Phipps AI, Weiss NS, Breslau ES, Burnett-Hartman AN, Corley DA, Doria-Rose VP, Green BB, Halm EA, Levin TR, Schottinger JE, Chubak J Risk of colorectal cancer and colorectal cancer mortality beginning one year after a negative fecal occult blood test, among screen-eligible 76-85-year-olds 2023 Oct 2;32(10):1382-1390. doi: 10.1158/1055-9965.EPI-23-0265. Epub 2023-07-14. PubMed
McCarthy AM, Tiro JA, Hu E, Ehsan S, Chubak J, Kamineni A, Feldman S, Atlas SJ, Silver MI, Kobrin S, Haas JS Factors associated with shorter-interval cervical cancer screening for young women in three United States healthcare systems 2023 Oct;35:102279. doi: 10.1016/j.pmedr.2023.102279. Epub 2023-06-11. PubMed
Selby K, Sedki M, Levine E, Kamineni A, Green BB, Vachani A, Haas JS, Ritzwoller DP, Croswell JM, Ohikere K, Doria-Rose VP, Rendle KA, Chubak J, Lafata JE, Inadomi J, Corley DA Test performance metrics for breast, cervical, colon and lung cancer screening: a systematic review 2023 Apr 11;115(4):375-384. doi: 10.1093/jnci/djad028. Epub 2023-02-08. PubMed
Del Vecchio NJ, Beaber EF, Garcia MP, Wheeler CM, Kamineni A, Chao C, Chubak J, Corley DA, Owens CL, Winer RL, Pruitt SL, Raine-Bennett T, Feldman S, Silverberg M Provider- and Facility-Level Variation in Pre-Cancerous Cervical Biopsy Diagnoses 2023 Apr;27(2):113-119. doi: 10.1097/LGT.0000000000000721. Epub 2023-01-17. PubMed
Chao CR, Chubak J, Beaber EF, Kamineni A, Mao C, Silverberg MJ, Tiro JA, Skinner C, Garcia M, Corley DA, Winer RL, Raine-Bennett T, Feldman S, Wheeler CM Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings 2023 Feb;12(3):3705-3717. doi: 10.1002/cam4.5226. Epub 2022-09-15. PubMed
Dalmat RR, Ziebell RA, Kamineni A, Phipps AI, Weiss NS, Breslau ES, Corley DA, Green BB, Halm EA, Levin TR, Schottinger JE, Chubak J Risk of colorectal cancer and colorectal cancer mortality beginning ten years after a negative colonoscopy, among screen-eligible adults 76-85 years old 2023 Jan 9;32(1):37-45. doi: 10.1158/1055-9965.EPI-22-0581. Epub 2022-09-13. PubMed
Kruse GR, Lykken JM, Kim EJ, Haas JS, Higashi RT, Atlas SJ, McCarthy AM, Tiro JA, Silver MI, Skinner CS, Kamineni A Provider beliefs in effectiveness and recommendations for primary HPV testing in three healthcare systems 2023 Jan 3;7(1). doi: 10.1093/jncics/pkac086. Epub 2022-12-05. PubMed
Chubak J, Dalmat RR, Weiss NS, Doria-Rose VP, Corley DA, Kamineni A Informative presence in electronic health record data: a challenge in implementing study exclusion criteria 2023 Jan;34(1):29-32. doi: 10.1097/EDE.0000000000001542. Epub 2022-09-16. PubMed
Kamineni A, Doria-Rose VP, Chubak J, Inadomi JM, Corley DA, Haas JS, Kobrin SC, Winer RL, Elston Lafata J, Beaber EF, Yudkin JS, Zheng Y, Skinner CS, Schottinger JE, Ritzwoller DP, Croswell JM, Burnett-Hartman AN Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines 2022 Nov;175(11):1582-1590. doi: 10.7326/M22-1139. Epub 2022-09-27. PubMed
Research
Improving cancer prevention and early detection
How KPWHRI is contributing to better cancer screening and better outcomes for patients.
Healthy findings blog
Improving reporting of cancer screening harms
Aruna Kamineni, PhD, MPH, discusses her recent study on how guidelines report screening risks.
innovating care
How to maximize screening for colon cancer
Research informs care as Kaiser Permanente Washington, exceeding 80 percent screening rate, launches home-based 'FIT First' pilot.
KPWHRI in the Media
Aruna Kamineni, PhD, MPH, comments on new study of cancer screening guidelines
NCI study analyzes the harms from cancer screening
Managed Healthcare Executive, Dec. 8, 2022
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.